Hanall Biopharma Co., Ltd.
Records under this name other than the patents Hanall Biopharma Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Back to Hanall Biopharma Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,416,098 | Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredient Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,464,042 | Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,993,446 | Biguanide derivative, a preparation method thereof, and a pharmaceutical composition containing the biguanide derivative as an active ingredient Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,376,480 | Biguanide derivative, a preparation method thereof, and a pharmaceutical composition containing the biguanide derivative as an active ingredient Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,133,110 | Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,321,742 | N1-cyclic amine-N5-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,540,325 | N1-cyclic amine-N5-substituted phenyl biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,580,490 | Uses of modified human tumor necrosis factor receptor-1 polypeptide Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,884,821 | N1-cyclic amine-N5-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,252,996 | N1-CYCLIC AMINE-N5-SUBSTITUTED Biguanide Derivatives, Methods of Preparing the Same and Pharmaceutical Composition Comprising the Same Formerly held In force · Low confidence | In force | Low confidence |